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Abstract: Communication of molecular species through dynamic association and/or 
dissociation at various cellular sites governs biological functions. Understanding these 
physiological processes require delineation of molecular events occurring at the level of 
individual complexes in a living cell. Among the few non-invasive approaches with 
nanometer resolution are methods based on Förster Resonance Energy Transfer (FRET). 
FRET is effective at a distance of 1–10 nm which is equivalent to the size of 
macromolecules, thus providing an unprecedented level of detail on molecular interactions. 
The emergence of fluorescent proteins and SNAP- and CLIP- tag proteins provided FRET 
with the capability to monitor changes in a molecular complex in real-time making it 
possible to establish the functional significance of the studied molecules in a native 
environment. Now, FRET is widely used in biological sciences, including the field of 
proteomics, signal transduction, diagnostics and drug development to address questions 
almost unimaginable with biochemical methods and conventional microscopies. However, 
the underlying physics of FRET often scares biologists. Therefore, in this review, our goal 
is to introduce FRET to non-physicists in a lucid manner. We will also discuss our 
contributions to various FRET methodologies based on microscopy and flow cytometry, 
while describing its application for determining the molecular heterogeneity of the plasma 
membrane in various cell types. 
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1. Background 
The major constituents of all living beings are nano-sized molecular species like lipids, proteins, 
carbohydrates and nucleic acids [1]. These molecules are constantly in communication with each  
other through complex yet specific interactions in a crowded molecular environment regulating the 
biological functions in an organism [2,3]. Therefore, uncovering the secrets in the way these molecules 
function requires an approach that would enable monitoring the molecular actions at nanometer scale. 
One of the first described methods capable of reaching nanometer resolution was based on the 
principle of Förster Resonance Energy Transfer (FRET), which nowadays is also referred to as 
fluorescence resonance energy transfer mainly owing to the usage of fluorescence-based probes for 
FRET applications. In the 1920s, Perrin first introduced the concept of dipole–dipole interaction  
and distance dependent transfer of energy without molecular collision [4]; however, the accurate 
quantitative theory of FRET occurring between two closely juxtaposed molecular species was 
correctly described by Theodor Förster in 1948 [5]. Experimental verification of this theory, primarily 
the distance dependence of FRET, was proven only in the late 1960s [6,7]. Importantly, with his 
insightful seminal papers, Lubert Stryer popularized FRET as a “Spectroscopic Ruler” [6,8].  
The application of FRET in biology gained momentum only in the last 20 years after huge technical 
advances in physical and biological sciences, integration of FRET with easy-to-use fluorescence based 
instruments and simple classification of the various modalities of FRET measurements. 
2. Introduction 
FRET is a collision-free, but distance-dependent photophysical process where radiationless transfer 
of energy occurs from an excited donor (D) fluorophore to a suitable acceptor (A) protein or 
fluorophore via long-range dipole–dipole coupling mechanism. Donor absorbs energy at shorter 
wavelength whereas acceptor has energy absorption at longer wavelength [9,10]. FRET occurs over 
interatomic distances due to resonance-based interaction of chromophores without transmission of 
photons from donor to acceptor species. Therefore, it is inaccurate to use fluorescence with the 
acronym FRET, since fluorescence involves emission of photons. At distances below 1 nm, collision 
between donor and acceptor would prevail, whereas at distances higher than 10 nm, photon emission 
by donor would be dominant. Therefore, FRET occurs only in the near field, which is in the range of 
1–10 nm [11,12]. Often FRET is envisioned as a phenomenon occurring between two spectroscopically 
different fluorophores, also termed heteroFRET. However, FRET can also take place between 
spectroscopically identical fluorophores under the condition that they have a small Stokes shift,  
i.e., small separation between excitation and emission spectral peaks. Energy transfer between like 
fluorophores is known as homoFRET. When the two molecules in close proximity are fluorescent 
species, the apparent changes that would occur due to FRET are reflected in the spectroscopic properties 
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of these fluorochromes, like fluorescence intensity, fluorescence lifetime, quantum efficiency and 
anisotropy [13,14]. FRET is intrinsically sensitive to molecular distance providing both quantitative 
and qualitative information leading to its widespread use in various disciplines of science. In fact, 
FRET is perfectly suitable for determining the large array of dynamic molecular events, including 
conformational change in macromolecules, cis- or trans- association/or assembly in macromolecules 
etc., regulating physiological events both under in vitro and in vivo conditions [10]. The Jablonski 
diagram represents the simplest explanation of the occurrence of FRET in terms of donor/acceptor 
excitation and emission (Figure 1). We aim to introduce FRET techniques to the biologists or bio 
(medical) researchers who can hugely benefit from FRET applications. Therefore, this review is not  
a comprehensive report on FRET; rather it entails the phenomenological description of the mechanism 
of FRET, highlights advantages and limitations and the type of information that can be gained from 
FRET by using various methodologies, and presents several examples of FRET applications in 
membrane biology. 
 
Figure 1. (a) The figure shows the Jablonski diagram demonstrating mechanism of Förster 
Resonance Energy Transfer (FRET). On absorption of energy, electrons in both donor and 
acceptor are excited from the ground state to an excited state, and they lose energy as 
fluorescence with rate constant kf(D) for donor or kf(A) for acceptor and non-fluorescence 
mechanisms with rate constant knf(D) for donor or knf(A) for acceptor. On the occurrence of 
FRET, excited energy of the donor is also lost via FRET to an acceptor with rate constant 
kFRET; and (b) Spectral overlap: The absolute requirement of FRET is illustrated in this 
figure. The symbols “λୣ୶ୈ ” and “λୣ୫ୈ ” or “λୣ୶୅ ” and “λୣ୫୅ ” indicate excitation (λex) and 
emission spectra (λem) of donor and acceptor fluorophores respectively with upper index 
letters denoting fluorophores. Essential spectral overlap in the case of heteroFRET 
(yellow) and homoFRET (blue) is also highlighted in the figure. 
Förster theory states that the efficiency of energy transfer (E) is a function of the inverse  
sixth power of the distance separating the two interacting molecules and “E” is expressed by the 
following equation: 
E = ܴ଴
଺
ܴ଺ + ܴ଴଺
 (1)
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In the equation above, “R” indicates the actual distance between donor and acceptor whereas “R0” 
represents the Förster distance, which is a characteristic distance at which the probability of energy 
transfer is 50%. Though, it is clear from Equation (1) that “E” is highly dependent on the magnitude of 
“R”, there are also other factors (see Equation (2)) that influence “R0” and correspond to the 
spectroscopic features of fluorescent donor and/or acceptor and their spatial orientation which can 
significantly affect energy transfer. 
ܴ଴ = 0.02108 [ߢଶ × ߔ஽ × ݊ିସ × ܬ]
భ
ల nm (2)
ߢଶ = (cosθୖ − 3cosθୈ cosθ୅)ଶ (3)
ܬ = න Fୈ(λ)ε୅(λ)
ஶ
଴
λସdλ (4)
In the above equations, “ĸ2” is the orientation factor describing the relative orientation between the 
dipoles of the donor emission and the acceptor absorption, “ΦD” is the fluorescence quantum yield of 
the donor in the absence of the acceptor, “n” is the refractive index of the medium, and “J” is the 
extent of overlap between the donor emission and acceptor absorption spectra. In Equation (3),	θୖ	 is 
the angle between the “D” and “A” dipoles whereas θୈ	and	θ୅ are the angles the “D” and “A” dipoles, 
respectively, subtend with the line connecting the donor-acceptor dipole origins (Figure 2b).  
In Equation (4), “λ” is the wavelength and ε୅(λ) and Fୈ(λ) are the molar absorption coefficient of the 
acceptor and the normalized fluorescence emission of the donor at wavelength “λ”. 
In practice, considering the use of fluorescent probes, the following set of conditions must be 
fulfilled in order to observe FRET: (I) The emission spectrum of the donor must overlap with the 
absorption spectrum of the acceptor. For a given FRET-pair, the larger the spectral overlap, the higher 
the Förster distance [15]; (II) The donor must have a high quantum yield; (III) The donor emission and 
acceptor absorption dipole moments must be oriented in favorable directions, which is numerically 
characterized by the orientation factor, ĸ2, ranging from 0–4. To observe FRET, ĸ2 should not be  
too small. FRET efficiency is the highest when the two vectors are parallel (ĸ2 = 4), whereas, FRET 
efficiency decreases with the increase in the angle between the two vectors. In fact, FRET efficiency is 
zero when the two vectors are in perpendicular position even in a case when two fluorescent probes  
are within FRET distance (ĸ2 = 0). For most biological applications considering the use of organic 
fluorophores, ĸ2 is usually taken as 2/3, which is an isotropic dynamic averaging, assuming that both 
donor and acceptor fluorophores can acquire all possible random orientations during the donor’s 
lifetime (Figure 2b) [16,17]. Furthermore, ĸ2 is also influenced by the nature of the microenvironment 
where donors and acceptors are suspended; (IV) Most importantly, the donor and acceptor must be 
close, but not too close to induce contact based quenching. Usually, the distance between 1 and 10 nm 
is reasonable (Figure 2a). 
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Figure 2. (a) A schematic representation of FRET between two molecules; (b) The 
orientation of emission dipole moment of donor and absorption dipole moment of acceptor 
is illustrated in this figure. “R” is the distance between the centers of donor and acceptor. 
θD is the angle between the transition dipole moment of donor and the line joining the two 
dyes while for the acceptor this angle is indicated as θA. The angle between the donor and 
acceptor dipole moments is θR. The possible virtual donor and acceptor fluorophore 
orientations are also presented in this figure, however, in reality the vectors are not exactly 
as depicted rather are random and can point in any direction of space; (c) Dependence of 
energy transfer on distance: A graph is presented here showing FRET efficiency (E) for 
three FRET-pairs with R0 values 3.9 nm (pyrene and coumarin), 5.6 nm (fluorescein 
isothiocyanate (FITC) and tetramethylrhodamine (TRITC)), and 7.4 nm (Alexa Fluor 546 
(Alexa 546) and Alexa Fluor 647 (Alexa 647)) [18]. It is obvious that with the increase in 
R0, the sharp rise or fall of the graph at the end of the curves is reduced, allowing the 
feasibility to monitor changes in “E” at that range. 
3. FRET: An Index for Sub-10 Nanometer Distances 
The efficiency of FRET has a strong dependence on the Förster distance (R0) and on the physical 
distance separating the donor and acceptor species (R). R0 is a characteristic feature of each donor and 
acceptor FRET-pair and can be estimated based on Equation (2). It is generally in the range of 4–8 nm. 
R0 values for FRET-pairs can be found in the literature for both organic dyes [18] and fluorescent  
proteins [18,19]. It is obvious from the Figure 2c that a FRET-pair with a larger R0, e.g., R0 of Alexa 
546-Alexa647 in comparison with pyrene-coumarin, accommodates a wider range of measurable 
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distance for “E” thus providing possibilities to determine small-scale changes in distances more 
effectively. In fact, “E” shows saturation at a distance below 0.5 R0 (E sharply attains 1) and above  
2 R0 (E dwindles to 0 rapidly). Thus, distances in the range of ~0.5 R0–~2 R0 can usually be measured 
by FRET. Beyond these distance limits, we can only state that the distances are below 0.5 R0 or beyond 
2 R0 [11]. The critical working distance of FRET also matches the dimension of many biological 
molecules, such as the size of proteins (a 30 kDa globular protein has a diameter of ~3 nm [19]), lipids 
and nucleotides, the distance between two interacting macromolecules or sites on multi-subunit  
proteins etc. FRET is therefore perfectly suitable for biological research resulting in the description of 
FRET as a “spectroscopic ruler” to probe intermolecular distances. The choice of a FRET-pair, 
however, depends on the type of biological questions and the available instrument for FRET studies. 
The spatial resolution of the conventional optical microscope is limited by diffraction to ~250 nm 
laterally, which is orders of magnitude larger than the average size of a protein molecule ranging 
within a few nanometers. This makes it difficult to predict whether the two molecules in the image 
obtained by traditional microscopes are in interaction or not. In such cases, exploitation of FRET 
increases the accuracy of co-localization of the molecules within the diffraction-limited spots. This 
provides a good contrast mechanism, and occurrence of FRET between two molecules is proof of 
potential molecular proximity. 
4. Lighting up Molecules for FRET 
Essentially, a prerequisite for FRET is to be able to visualize molecules. Often, with some 
exceptions, biological molecules are not self-fluorescent. Therefore, tagging of target molecules with 
fluorescent markers is required. There are three popular approaches which can render the molecules of 
interest fluorescent: (1) An approach based on fluorescent affinity reagents prepared by conjugating 
fluorophores to affinity probes [20] (2) An approach based on fluorescent protein (FP) requiring fusion 
of DNA of target protein and fluorescent protein [21] and (3) An approach based on bioorthogonal 
chemistry for labeling proteins or an in vivo labeling approach in which a target protein is fused with a 
tag making it amenable for chemical labeling in living cells [22]. 
4.1. An Approach Based on Fluorescent Affinity Reagents 
Antibodies are the most widely used affinity reagents in biological research owing to their high 
affinity and exceptional specificity towards the target molecule. They are also easy to generate, 
virtually against any known molecules, with the well-established hybridoma technology [23]. 
Fluorophore conjugated antibodies are popular as a probe for FRET or cellular imaging traditionally. 
Derivatives of organic fluorophores having functional groups with reactivity toward relevant side-chain 
groups, such as amines and sulfhydryls, in a protein are easily available. The literature also abounds 
with numerous straightforward bioconjugation protocols making preparation of fluorescent antibodies 
a relatively simple task nowadays [20,24]. However, the most widely used methods for bioconjugation, 
involving amine targeting, is not site-specific and, rather, is random in nature due to the abundance of 
amines in proteins [20,24], a condition which is not completely ideal for FRET measurements. 
Additionally, despite the presence of a large number of commercial fluorophores with emission ranges 
extending from the UV to the infrared spectrum [25], their suitability for FRET investigations is not 
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easy to judge because of the difficulty in obtaining complete information about their photophysical 
features. Nonetheless, data about several fluorophore FRET-pairs in the literature are of great help in 
choosing the right fluorophores though it restricts us to only limited sets of few good FRET-pairs for 
studying membrane proteins [15,25,26]. Most of our FRET studies on membrane proteins were based 
on fluorophore-antibody conjugates. We have demonstrated earlier that fluorescent primary antibodies 
are preferred for FRET measurements. However, indirect labeling using secondary fluorescent 
antibodies can also be used to detect primary non-fluorescent antibodies. Although, such a scheme 
would lead to a decrease in the FRET efficiency between the probed proteins because of the greater 
separation of donors and acceptors as a result of the increase in the size of the antibody labeling 
complex. We also cannot rule out the possibility of detecting FRET between two proteins at distances 
greater than 10 nm. The use of polyclonal secondary antibodies can complicate the interpretation of 
FRET as well [15,27]. Antibodies with their large-size, molecular weight of ~150 kDa, and bivalent 
binding properties can also pose other problems. Since the latter circumstance can induce artificial 
clustering, there is a growing interest in alternative affinity reagents like aptamers—most often 
oligonucleotides [28], affibodies [23], synthetic engineered antibodies or phage-display antibodies [28,29] 
and single-domain antibodies (e.g., nanobodies engineered from heavy-chain camelid antibodies) [30] 
with target specificity equaling or exceeding that of conventional IgGs. Labeling of intracellular 
antigens with fluorescent antibodies also requires cell fixation and permeabilization. Fixation itself can 
alter the geometry and distribution pattern of molecules inside the cell [31] and can also damage or 
mask the antigenic structure leading to abrogation of antibody binding [32]. Overall, fluorescent 
affinity reagents have facilitated in vitro studies on protein structure and protein–protein interaction; 
however, it has not been successful in addressing questions about the real-time dynamics of molecules 
in living cell, which is important for studying weak or transient molecular interactions that might occur 
in natural cellular milieu. 
4.2. An Approach Based on Fluorescent Proteins 
The possibility of recombinantly fusing the target molecule with a fluorescent tag augmented the 
interest in FRET applications and also made it possible to follow biological processes in time in 
different cellular compartments in a non-invasive manner. Among the most popular tags are green 
fluorescent proteins (GFPs) and its derivatives. Like organic fluorophores, now we have a palette of 
different colored FPs, spanning the entire visible spectrum, as a result of GFP engineering and  
newer discoveries from corals and several unrelated species including crustaceans and lancelets. The 
spectrum also includes the modern red fluorescent proteins (RFPs) with larger Stokes shift and with 
emission maxima exceeding 560 nm [33–36]. In fact, the library of FPs offers a huge collection of 
donor-acceptor pairs suitable for FRET experiments [35]. However, CFP (cyan) and YFP (yellow) is 
still the most widely used donor-acceptor pair [37]. Recently, a combination of Clover and mRuby2, 
emitting green and red fluorescence, respectively, was found to increase the dynamic range and 
detection sensitivity of FRET in comparison with CFP-YFP pair [38]. Post-2007, several new FP 
variants have emerged with better photophysics compared to GFPs and RFPs [35]; therefore, 
quantitative examination of FPs suitable for FRET measurements in live cell imaging is an avenue that 
is open for exploration. In contrast to the approach based on fluorescent affinity reagents, FPs offer the 
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possibility for site-specific conjugation to molecules and have revolutionized life science studies. 
However, FP fusion proteins are not free of problems. The significant molecular mass of FPs, e.g.,  
27 kDa (240 aa) for GFP, might alter expression, folding and distribution of the target protein and can 
impair protein function [39–41]. Most FPs show some tendency of self-association, especially when 
they are fused to other proteins; thus, they may induce artificial clustering. In fact, the self-association 
behavior of fluorescent proteins in physiological conditions might be completely different [40,42]. 
Therefore, the behavior of fusion proteins may not be the exact reflection of that of endogenous  
proteins and the requirement of ectopic expression further complicates it. FPs also show tremendous 
heterogeneity in maturation, sensitivity to pH, ionic strength, photobleaching kinetics [25,36,41]  
and possibly their behavior in various cell types [43]. The spectroscopic features of FPs, such as 
brightness and photostability, are relatively inferior to that of organic fluorophores [36,43]. Further, 
switching to another color requires either another plasmid vector having target protein fused to another 
FP or recloning, making exchange of colorsa difficult process. 
4.3. An Approach Based on Bioorthogonal Chemistry 
To address some of the issues with FPs, bioorthogonal chemistry based labeling approach was 
developed. The idea here is to express a tag that would allow site-specific labeling in the target protein 
with luxury for swapping of fluorophores with known photophysical features. Several new methods 
based on this concept have emerged recently which include expression of tags that could bind specific 
ligand, enzyme mediated ligation of tag with fluorophore substrate, and unnatural amino acid incorporation 
into proteins for specific chemical labeling. A detailed description of these methodologies is not the 
subject of this review but some excellent reviews have been published earlier [22,43,44]. From our 
perspective, we find SNAP and CLIP technology to be relatively more flexible for FRET 
measurements than the other bioorthogonal approaches, though, the combination of bioorthogonal 
approaches can work successfully. Both SNAP and CLIP proteins are derivatives of human DNA 
repair protein O6-alkylguanine-DNA alkyltransferase (hAGT) performing self-attachment but with 
preferential reactivity towards O6-alkylylguanine or O6-benzylguanine and O2-benzylcytosine 
derivatives as substrates, respectively. Because of these orthogonal substrate specificities, SNAP- and 
CLIP-tagged fusion proteins can be simultaneously labeled with different molecular probes bearing 
fluorophores. SNAP- and CLIP-tagged proteins are similar in size (~20 kDa) to FPs; however, they 
confer an important advantage with respect to the choice in organic fluorophore that can be used to 
label the tagged fusion proteins for various types of FRET experiments [45]. In comparison with FPs, 
biological research with SNAP- and CLIP-tagged proteins is still in its infancy; therefore, the possible 
effects of these tags on the expression, maturation, localization and function of the target proteins are 
uncertain. However, it is known that the life-span of hAGT is dramatically reduced and is targeted  
for ubiquitin degradation upon forming a complex with its substrate [46]; therefore, SNAP- and  
CLIP-tagged fused proteins may have reduced half-life in comparison with their endogenous 
counterparts. Nonetheless, in a recent study, it was demonstrated that SNAP-tagged fusion proteins 
retained the normal distribution features of wild type protein whereas several FPs induced artifacts  
due to clustering of the fused protein [40]. Endogenous hAGT is also known to react with SNAP 
substrates, though less efficiently, which would lead to off-target background noise. However, 
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endogenous hAGT is comparatively very low in most cell lines and can be avoided when hAGT 
deficient cell lines are used [45]. In contrast to FPs, maturation and fixation of SNAP- and CLIP-fused 
proteins do not seem to be an issue either because fluorophores with known photochemical features are 
used [25,36,47]. Importantly, these methods can be used in conjunction with tetracysteine (CCXBCC, 
where X and B can be any amino acid except cysteine), tetraserine (SSPGSS) or Halotag based 
approaches amongst others providing multiple efficient ways for multicolor labeling [22,25,43,44]. 
Thus, bioorthogonal labeling of SNAP- and CLIP-tagged proteins seems flexible, non-invasive and the 
most suitable strategy for FRET experiments. However, any FRET experiment should be cross-checked 
with an alternative strategy for confirmation of the findings. 
5. Is Your Instrument FRET Friendly? 
In principle, any instrument capable of recording fluorescence emission can be used for measuring 
FRET as long as suitable fluorophores are available and the corresponding filters and detectors are 
present in that system. The theoretical foundation of FRET was laid out on the basis of collision 
experiments of several metallic elements in the vapor phase using a spectroscope [4]. Therefore, early 
FRET experiments were mainly performed using spectrofluorometry [6,48,49] then it slowly 
progressed to flow cytometry [49–51] and various microscopies [21,49,52–54] or lately to laser 
scanning cytometry [55–57]. However, generally the choice of instruments for FRET measurements is 
driven by biological goals because each of these instruments can deliver specific types of answers.  
Of course, the most versatile of all the instruments is the microscope; therefore, many FRET approaches 
are devised exploiting the capabilities of microscopy to decipher the spectroscopic information of 
fluorophores. Thomas Jovin and colleagues proposed some new microscopic approaches and also 
prepared a catalog of FRET techniques in 2003 [58]. Likewise, critical evaluation of many of the 
widely used FRET methods in spectrofluorometry, flow cytometry and microscopy has also been 
performed in [59]. Therefore, our goal in this section is just to describe the merits and demerits 
associated with each of these widely used instruments for FRET. FRET crawled its way into biology 
through physics and chemistry. Therefore, it is no surprise that the fluorometer was the most 
commonly used instruments for measuring FRET in the early days, even today in many places, 
because of its easy accessibility. Donor quenching and acceptor sensitization based FRET experiments 
are primarily performed in spectrofluorometry. Fluorescence signals are collected from the cell 
suspension either in the cuvette or from the cells fixed on slides. Therefore, the acquired signals are an 
average from thousands of cells. These are good for statistical accuracy, but possible heterogeneity 
among cells in the sample is hidden. Measurements from fluorometer thus are blind-folded from the 
details of each cell and they provide population averages of parameters. Since samples are measured in 
solution, the presence of dead cells or cellular debris (which can often be far brighter), free 
fluorophores (especially with low-affinity fluorophore labels), and cellular autofluorescence can  
affect the measurement significantly [50,60]. The contribution of the aforementioned factors in the 
measurement accentuates the notion that performing FRET for lowly expressed proteins is almost 
impossible or unreliable due to distortion in signals with fluorometry that in many cases would require 
cell-by-cell correction for autofluorescence [27]. Because of the measurement procedure, sample 
should be prepared very carefully, for instance, proper washing should be performed and contribution 
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of free fluorophores to the fluorescence intensity should be minimized. Microscopy and flow 
cytometry can overcome the above limitations of spectrofluorometry. However, relatively very few 
cells can be investigated in microscopy compromising its statistical reliability [50]. Microscopy is 
more suitable for real-time visualization of kinetic molecular events capturing microsecond or 
nanosecond cellular changes in living cells and providing crucial information regarding the functioning 
of biological molecules [61]. FRET is commonly used with wide-field microscope but has been 
successfully implemented in confocal, multi-/two-photon, fluorescence lifetime and fluorescence 
polarization microscopes, each with their own distinct advantages. For example, wide-field microscope 
collects the emission signals from both above and below the focal plane, reducing the quality of the 
image, whereas, confocal microscopes can reject these out-of-focus signals giving sharper images.  
In combination with fluorescence lifetime or anisotropy, the sensitivity of FRET approach is  
enhanced providing a spatial map and temporal information pixel-by-pixel in different contrast 
patterns [13,61,62]. Therefore, microscopy is more suitable for studying dynamic molecular events and 
heterogeneity in or within a cell [63,64]. Regardless of the benefits of microscopes for FRET 
measurements, the underlying disadvantage of all microscopes is that they require specific training on 
the proper usage of these microscopes and the ability to record high-quality fluorescence images  
in the absence of any artifacts. A flow cytometer on the other hand can measure thousands of cells 
within a minute. Therefore, the results are more robust and reliable than those from microscopes 
statistically; however, information can only be obtained on a cell-by-cell basis. Nonetheless, it allows 
categorization of a population of cells from the same sample and is capable of elucidating the 
differences in “E” in correlation with any other cellular parameters. Importantly, what flow cytometer 
can achieve is the possibility of sorting the cells based on cellular heterogeneities and energy  
transfer [65,66]. However, the disadvantage of using flow cytometer is the nature of measurement of 
cells. Cellular suspension is necessary which means detachment of cells from their substrate should be 
performed. Removal of cells from their natural environment either mechanically or by enzymatic 
treatment can result in changes in cellular parameters. Furthermore, flow cytometry fails to provide 
information regarding heterogeneities within the cell and about the time-course of cellular responses at 
single cell level, the attribute at which microscopy excels [60]. The superiority in statistics offered by 
flow-cytometric measurements thus compensate for the lack of subcellular information that can be 
obtained in microscopy [15,60]. High-throughput imaging technologies can combine the complementary 
features of both microscopy and flow cytometry. We have recently demonstrated the applicability  
of FRET with a laser scanning cytometer (LSC), LSC-FRET, yielding FRET efficiencies comparable 
to those obtained from a flow cytometer or a confocal microscope [55]. One major advantage of LSC  
is that spatial resolution and information about subcellular structures can be generated under native  
in situ conditions with decent statistics. LSC yields information on a pixel-by-pixel and cell-by-cell 
basis with the capability for temporal cellular response analysis in cells. Thus, LSC advances the 
features of flow cytometry with a small sacrifice in the number of cells that could be analyzed in the 
specific time-frame but with the incorporation of advantages of confocal microscopy. Likewise, a 
high-throughput FRET technique based on total internal reflection fluorescence microscopy (TIRFM) 
was also published a few years ago [67]. The inherent advantage of FRET-TIRFM is similar to that of 
LSC-FRET. However, it harbors few additional benefits specific to the use of evanescent wave for 
illumination of samples. Firstly, evanescent wave generates low autofluorescence because TIRFM 
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excitation is limited to a thin layer (~100 nm, mainly plasma membrane). Secondly, in TIRFM 
fluorophores located closer to the plasma membrane are preferentially excited; therefore, FRET-TIRFM 
is efficient in removing non-membrane fluorescence. In fact, TIRFM is said to be far superior to 
confocal microscopes at detecting plasma membrane fluorescence [67]. Thus, it is optimal for  
high-throughput FRET related to membrane proteins. 
In the paragraphs below, we will discuss several methods that are generally used in biological 
systems for measuring FRET and subsequently we will also elaborate on the various applications of 
FRET based techniques, especially on our contribution towards developing and applying FRET based 
methods for studying membrane proteins. 
6. Methods for Measuring FRET 
Fluorescence has many spectroscopic dimensions that can be sensitively monitored and fortunately, 
the manifestation of FRET is the alteration of these spectroscopic features. Therefore, a multitude of 
techniques can be employed to measure FRET. Several excellent reviews have been published  
earlier [11,13,58,68–71] where extensive theoretical details are underlined for quantitative analysis of 
FRET. Types of FRET and the effect of FRET on the spectroscopic features of fluorophores are 
schematized in Figure 3. The most notable FRET measurements are based on the following three 
approaches: (1) Fluorescence intensity based approach; (2) fluorescence lifetime based approach;  
and (3) fluorescence anisotropy based approach. We have played a seminal role in the development of 
a ratiometric flow-cytometric FRET (FCET); therefore, FCET will be discussed extensively here, 
whereas, other FRET methods will be presented through a few mathematical expressions for  
easy understanding. 
 
Figure 3. Cont. 
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Figure 3. (a) Schematic representation of types of FRET measurements based on 
photophysical features; and (b) This figure illustrates the effect of heteroFRET and 
homoFRET on fluorescence intensity (left panels), fluorescence lifetime (middle panels) 
and fluorescence anisotropy (right panels). Here, “D” and “DA” quoted symbols, including 
the ones in the subscript, represent donor only and FRET samples. In heteroFRET, donors 
and acceptors are fluorophores with different spectroscopic features. In the upper graph in 
the left panel, the emission of donor and FRET samples on excitation by the donor 
excitation wavelength are depicted for simplicity. The green and red curves correspond to 
the donor and acceptor emission spectra, respectively, in the left panels. In the lower graph 
in the left panel, there is only a green curve since both the donor and the acceptor are 
spectroscopically identical. In the middle and right panels, only the time-dependent donor 
emission (middle) and anisotropy (right) are shown in the absence and presence of the 
acceptor. The only manifestation of homoFRET is the decrease in anisotropy and no 
change in fluorescence intensity or fluorescence lifetime of the donor fluorophore. 
6.1. Fluorescence Intensity Based Approach 
6.1.1. Donor Quenching Method 
This is the most straight-forward and the easiest method for quick measurement of FRET.  
It requires an inspection of donor fluorescence in singly (donor only) and doubly (donor-acceptor) 
labeled samples. The consequence of FRET is the decrease in the fluorescence intensity of the donor in 
the doubly labeled sample in comparison with the intensity of the donor from the donor only sample. 
However, this method is error-prone because any quenching observed in the donor fluorescence 
intensity is assumed to be due to the presence of acceptors. Since the donor intensity is measured in 
two different samples (donor-labeled and donor-acceptor double-labeled), any difference in the 
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expression level of the labeled antigens, alterations in antibody affinity and spectral cross-talk between 
the acceptor and donor fluorescence can lead to a difference between the donor intensity in the two 
samples. Obtaining the mean fluorescence intensity from a large population of cells minimizes the 
variation in fluorescence at the individual cell level. However, this also prevents donor quenching 
FRET from providing FRET information on a cell-by-cell basis, thus only mean FRET efficiency 
representative of a population of cells can be obtained. Therefore, this approach is mainly suitable for 
flow cytometry or spectrofluorometry based FRET studies [10,15,19]. Controls especially to identify 
competition in antibodies used for labeling the proteins should also be considered. One should make 
sure that the antibodies do not influence the binding of each other. If any, correction should  
also be performed for acceptor spill-over in the donor channel [15,19]. Intensities are measured by 
exciting the sample at the absorption peak of the donor and detecting fluorescence at the emission peak 
of the donor. 
Assuming “FD” is the fluorescence intensity of the donor sample and “FDA” is the fluorescence intensity 
of the donor and acceptor labeled sample, energy transfer is calculated with the following equation: 
E = 1 − ܨୈ୅ܨୈ  (5)
Both FD and FDA have to be background-corrected, i.e., the fluorescence of unlabeled cells has to  
be subtracted. 
6.1.2. Acceptor Photobleaching Method 
This is mainly a microscopy-based method. Importantly, FRET is estimated from information 
obtained after imaging a single sample. The general principle is to compare the fluorescence intensity 
of the donor before and after photodestruction of acceptor species. In the case of occurrence of FRET, 
there is an increase in the fluorescence intensity of the donor (donor dequenching) after bleaching of 
acceptors. Since high-intensity laser is used for bleaching of acceptors and acceptor molecule is 
irreversibly switched off, but remains physically connected to the donor even after bleaching, this 
approach has a few drawbacks. For example, generation of dark acceptors (non-fluorescent acceptor 
products, but capable of donor quenching), incomplete photobleaching of acceptor molecules and 
bleaching of donor species are still possible. Likewise, photobleaching of acceptors can also yield 
acceptor degradation products with an emission profile similar to that of donor molecules. Importantly, 
photodestruction of fluorophores means repeated measurements of the same sample is not possible 
precluding real time information on macromolecules [59,71] although identification of photoswitchable 
dyes [72] and fluorescent protein [73] has offered possibilities for dynamic measurements. Photosensitive 
acceptors and photostable donors are perfect for the acceptor photobleaching technique. Importantly, 
precaution should be taken to avoid movement of cells during photobleaching. The mathematical 
expression for the calculation of energy transfer (E) is analogous to Equation (5) except that FDA is 
replaced with the fluorescence of donor before acceptor bleaching and FD is substituted by the 
fluorescence of the donor after photobleaching. 
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6.1.3. Sensitized Acceptor Excitation Method 
FRET measurement based on quantification of sensitized emission of the acceptor is the most 
reliable among all intensity-based methods. Sensitized emission of acceptor is the amount of acceptor 
emission in the FRET channel due to resonance transfer of excitation energy from donor to  
acceptor [59]. Simultaneous measurement of individual fluorescence emissions from donor and 
acceptor from the same sample, in comparison with multi-samples, excludes problems related to 
variation, such as changes in donor density or fluorescence quantum yield [59,68]. Nonetheless,  
FRET estimations are more accurate and easier to perform in a case when donor and acceptor 
emissions are well separated. Otherwise, this method invites the introduction of several correction 
factors related to fluorophore cross-talk, i.e., the reciprocal excitation of donor and acceptors at the 
excitation wavelength of the other dye, and bleed-through of fluorescence emission of the donor and 
the acceptor to detection channel corresponding to the other dye. Independent control samples of donor 
and acceptor can help compensate the issues related to the above problems. Numerous methods have 
evolved with a goal of quantifying sensitized acceptor signal. Although quantitative approaches 
determining the FRET efficiency rigorously are preferred [53], semi-quantitative method providing 
uncalibrated FRET indices with dubious theoretical background also abound in the literature [59]. 
FRET indices are instrument dependent relative values designed according to the aims of studies. They 
are qualitative in nature, however, some of them seem to be more sensitive and consistent in cases 
where FRET efficiency based methods tend to suffer, for instance, when the ratio of donor to acceptor 
is lower than 1 [59]. With its simple mathematical framework, these approaches would seem rather 
attractive to biologists who are more concerned about learning the possibility of interactions between 
two macromolecules in a simple “yes” or “no” format or knowing the consequence of a biological 
response in the association of proteins in relative terms. Based on the literature, methods for 
measurement of sensitized emission can be categorized into three groups with the basic difference 
being the process of analyzing FRET signals: (1) Two-channel emission or excitation ratio 
measurement; (2) three-channel emission measurement; and (3) spectral analysis for FRET. 
Two-Channel Emission or Excitation Ratio Measurement 
Two channel emission ratio measurement has been applied a lot both in microscopy [74,75] and 
flow cytometry [76,77] as sensors of protein–protein interactions. Basically, the practice is to 
illuminate the doubly (donor and acceptor) labeled sample with the donor excitation wavelength, then, 
collect the signals in both donor and FRET channels, i.e., in the wavelength range corresponding to  
the emission peak of the donor and acceptor, respectively. A FRET index defined as the ratio of 
fluorescence intensities in the FRET and donor channels are widely used owing to the fact that the 
ratio is fairly consistent [19,52,78]. An alternative two-channel excitation ratio measurement has also 
been described before, where measurements at the emission wavelength of acceptor were taken upon 
consecutive excitation of the FRET sample with donor (FRET channel) and acceptor (acceptor 
channel) wavelengths. In this case, a parameter proportional to the FRET efficiency is expressed as the 
ratio of fluorescence in the FRET channel to the fluorescence in the acceptor channel [78,79]. 
Primarily, the above methods are ignorant to multiple cross-talks and bleed-through features of 
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fluorophores such as direct excitation of the acceptor at the donor absorption wavelength. However, 
these methods are very useful as long as the ratio of the concentrations of donors and acceptors is 
constant such as in intramolecular FRET studies [52,54] involving FRET-sensors. 
Three-Channel Emission Measurement 
Three-channel emission measurement requires collection of three independent signals from the same 
sample. These signals differ either in the wavelength of excitation or in a spectral range of detectors for 
recordings. In fact, this method is similar to the two-channel measurement with an additional third 
channel making rigorous deductions of non-FRET signals possible. Numerous studies have been 
published representing such a set-up with varying level of stringency with regards to cross-talk or 
bleed-through corrections [59]. For three-channel measurement, assessment of FRET has been 
demonstrated both in terms of FRET indices [52,53,80,81] and FRET efficiencies [15,54,68,69,82,83]. 
Measurements require collection of signals for donor alone, acceptor alone and doubly (donor-and-
acceptor) labeled samples under the same circumstances. Below, we will describe three of the most 
popular FRET index based three-channel measurements with FRET terminologies used by the 
respective authors: 
(a) Corrected FRET (Fc) method: This method was introduced by Youvan et al., for epifluorescence 
microscope [80]. They simply generated a FRET image corrected for fluorescence from background 
and bleed-through. However, the contribution of reciprocal cross-talk excitation in donor and acceptor 
channels, which were minimal in their case, was not considered during the calculation. Similarly,  
the method does not perform normalization for concentration of donors and acceptors. Therefore,  
it inherently suffers from the issues related to variability in fluorophore concentration. In fact, even at 
the same FRET efficiency, the FRET signal is different for samples in which various concentrations of 
donors and acceptors are used. Thus, it is suitable under conditions when the donor to acceptor 
concentration is constant or known beforehand. The corrected FRET was expressed in the following form: 
ܨୡ = 	ܨ୤	– [(ୢܨ /ܦୢ)× D୤] – [(ܨୟ/ܣୟ) × ܣ୤] (6)
In Equation (6), F, D and A represent FRET, Donor and Acceptor channels, respectively, whereas 
subscripts “f”, “d” and “a” represent FRET, donor and acceptor samples, respectively. The spectral 
bleed-through for donor (Fd/Dd) and acceptor (Fa/Aa) are calculated from donor only and acceptor  
only samples, respectively. It is also assumed that the images were background subtracted in the  
above equation. 
(b) FRET net (FRETN) method: Gordon et al. presented a FRETN method to overcome the 
underlying problem with the Fc method. Fc is linearly proportional to the concentration of 
fluorophores; therefore, they proposed that Equation (6) should be additionally normalized by the 
product of donor and acceptor signals [54]. This new method, however, overcompensates by dividing 
the Fc value with both donor and acceptor intensities. Therefore, FRET values flatten out at higher 
donor and acceptor intensities whereas it is fairly sensitive at low donor and acceptor intensities. Thus, 
this method generates FRET values with high standard error (80%) affected by concentrations of 
donors and acceptors [84]. 
FRETN = ܨୡ/ ܩ × ܦ୤ × ܣ୤ (7)
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The notations in Equation (7) are similar to that of Equation (6). A constant “G” is a parameter 
which relates the loss of donor signal to the increase in acceptor signal as a result of FRET (please 
refer to Equations (15) and (16) for “G” which is equivalent to “α” in the section below). 
(c) Normalized FRET (NFRET) method: In order to reduce the inconsistency of the FRETN method, 
Xia et al introduced the normalization procedure for Fc with the product of the square root of donor 
and acceptor signals [84]. This renders FRET independent of local concentration of fluorophore. 
However, NFRET is still not linear with changes in E values and fractional occupancy; therefore, it is not 
adequate for stoichiometric measurements of binding interactions [85]. 
N୊ୖ୉୘ = ܨୡ/ඥܦ୤ × ܣ୤ (8)
Several other methods have also been published where the basis of normalization of FRET value is 
with acceptor concentration [81,86]. 
Experimental results obtained using FRET indices from different instruments are not comparable 
because FRET indices depend on system parameters such as excitation intensities and detection 
efficiencies of the instrument [21]. Therefore, it is more relevant to express FRET through an  
instrument-independent, but quantitative parameter such as FRET efficiency. Assuming that the  
FRET-pair is red-shifted, which minimizes autofluorescence [27], and the contribution of background 
is negligible, FRET efficiency can be easily computed by solving a set of three linear equations 
corresponding to the signals from a FRET sample. They are expressed as a function of unquenched 
donor (ID), the FRET efficiency (E) and intensity from the acceptor in the absence of FRET (IA).  
To maintain consistency, we are using similar terminologies as in our previous papers [15,68,69,82].  
The following equations are based on FCET [15,68], although, we also implemented it in  
microscopy [69,70]. First, we would like to introduce the correction factors, which need singly labeled 
samples of donor and acceptor, so that it becomes easy to follow the equations. Correction factors result 
from spill-over and cross-excitation between donor and acceptor fluorophores, thus, are necessary for 
eliminating non-FRET signals. In a general case, four different “S” factors are used, namely S1, S2, S3  
and S4. 
S1 and S3 characterize the spill-over of donor intensity to the FRET (I2) and acceptor (I3) channels, 
respectively, and are determined using donor only labeled sample. 
S1 = ூమூభ , S3 = 
ூయ
ூభ (9)
S2 and S4 characterize the spill-over of acceptor intensity to the FRET (I2) and donor (I1) channels, 
respectively, and are determined using acceptor only labeled sample. 
S2 = ூమூయ , S4 = 
ூభ
ூయ (10)
where I1, I2 and I3 correspond to intensities measured in the donor, FRET and acceptor channels, 
respectively. The excitation (λex) and emission (λem) wavelength for each of the intensities is defined in 
the parenthesis of Equations (11)–(13). For instance, the abbreviation in the symbol (λex,D; λem,D) 
means excitation at the wavelength corresponding to the donor absorption band, and emission detected 
at the wavelength corresponding to the donor emission wavelength range. The uppercase letters “D” or 
“A” in the symbols represent donor and acceptor, respectively. 
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ܫଵ൫λୣ୶,ୈ; λୣ୫,ୈ൯ = ܫୈ(1 − E) + ܫ୅ × ܵସ + ܫୈ × ܧ × α ×
ܵସ
ܵଶ (11)
ܫଶ൫λୣ୶,ୈ; λୣ୫,୅൯ = ܫୈ(1 − ܧ) × ଵܵ + ܫ୅ × ܵଶ + ܫୈ × ܧ × α (12)
ܫଷ൫λୣ୶,୅; λୣ୫,୅൯ = ܫୈ(1 − ܧ) × ܵଷ + ܫ୅ + ܫୈ × ܧ × α ×
1
ܵଶ ×
ϵ஛ఽୈ 	ϵ஛ీ୅ 	
ϵ஛ీୈ ϵ஛ఽ୅
 (13)
Here, “߳” stands for molar absorption coefficient of “D” and “A” molecules shown by the upper 
indices at donor (λୣ୶,ୈ) or acceptor wavelengths (λୣ୶,୅). Often, S3, S4 and the molar absorption ratio, 
ቆ஫ಓఽ
ీ 	஫ಓీ
ఽ
	
஫ಓీ
ీ ஫ಓఽ
ఽ ቇ, are negligible, as with the Cy3-Cy5 FRET-pair when measured on a FACSCalibur (BD 
Bioscience, San Jose, CA, USA). Thus, solving Equations (11)–(13) would yield “E” in the following 
form (see references [15,68] for the derivation): 
E = ܫଶ − ܫଵ ଵܵ − ܫଷܵଶα ܫଵ + ܫଶ − ܫଵ ଵܵ − ܫଷܵଶ (14)
It is also clear from the above set of equations that calculating “E” in ratiometric FRET requires 
determining a factor “α”, which has been widely used as “G” in microscopy, to correct for the 
differences in the quantum yield of the donor and acceptor and in the detection efficiencies of the 
donor in the donor channel and the acceptor in the FRET channel. “α” relates the loss of donor 
fluorescence to the sensitized emission of the acceptor. 
Classically, “α” is expressed as in the equation below: 
α = ܳ୅ η୅ܳୈ ηୈ  (15)
where “QD” and “QA” are the fluorescence quantum yields of the donor and acceptor fluorophores, 
respectively, and “ηD” and “ηA” are the detection efficiencies of the donor in the donor channel and  
the acceptor in the FRET channel, respectively. Since both the quantum yield and the detection 
efficiencies are difficult to determine or calculate, numerous ways of calculating “α” factor have  
been reported previously though not without the challenges owing to the underlying variables. The 
interested readers are referred to the cited references for learning various approaches of determining “α” 
factor in microscopy [21,55,69,70,83,85] and flow cytometry [15,55,65,87]. One of the simplest 
approaches for calculating “α” is based on labeling two separate samples. One of the samples is labeled 
with a donor-tagged antibody and the other with an acceptor-tagged antibody. In such a case, “α” can 
be calculated according to the following equation: 
α = ܫଶ,୅ܫଵ,ୈ ×
ܤୈ
ܤ୅ ×
ܮୈ
ܮ୅ ×
ϵ஛ీୈ
ϵ஛ీ୅
 (16)
where I2,A and I1,D are the intensity of the acceptor-labeled sample measured in the FRET channel and 
the intensity of the donor-labeled sample measured in the donor channel, respectively. Likewise, “BD” 
and “BA” are the mean number of epitopes labeled by the donor-conjugated and acceptor-conjugated 
antibodies, respectively, and “LD” and “LA” denote the labeling ratios (i.e., number of fluorophores/ 
antibody) of the donor-conjugated and acceptor-conjugated antibodies, respectively. For the sake of 
simplicity, it is advisable to label the same epitope with the donor- and acceptor-conjugated antibodies, 
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so that BD = BA. Unfortunately, the method described above requires measuring a large number of 
cells, so that the mean intensities (I2,A and I1,D) are reliably determined, which is difficult to achieve in 
microscopy. Alternatively, “α” can be calculated by labeling the same membrane protein with two  
non-competing antibodies binding to distinct epitopes but far enough to avoid any occurrence of 
FRET. One of the antibodies should be donor-tagged, while the other should be acceptor-conjugated. 
This approach ensures that the BD/BA ratio is equal to 1 since the intensities I2,A and I1,D are measured 
on the same cells. Thus, “α” can be easily calculated from Equation (16) with BD/BA = 1. If the 
requirement for no FRET cannot be met, the energy transfer taking place between the donor- and 
acceptor-labeled antibodies has to be taken into consideration [55,88]. 
Despite the use of such a systematic method for calculating “E”, satisfactory results are still difficult 
to obtain for proteins with low expression levels. Thus, in cases when the signal to noise ratio is very 
low, accurate FRET calculations require cell-by-cell correction for autofluorescence and selection of  
a FRET-pair with long emission wavelength. This improvement reduces the dispersion of FRET 
histograms and thereby improves the sensitivity of FRET analysis [15,27,69]. Likewise, we have  
also recently introduced an efficient method applicable in such cases called Maximum Likelihood 
Estimation (MLE) of FRET efficiency. The method is based on the assumption that photon detection 
by detectors follows Poissonian statistics [63]. We developed a computational tool applying the 
Poisson function to I2 intensity expressed as a function of I1 and I3 after solving Equations (11)–(13). 
The method thus predicts the joint probability of photon numbers received by the donor, FRET and 
acceptor channels. The presented algorithm assigns a single FRET efficiency based on the likelihood 
of all three measured intensities to each pixel. Therefore, outlier pixels with low probabilities for the 
determined FRET efficiency can be easily excluded from the analysis thus improving the accuracy of 
the calculation significantly. The only drawback is that MLE of FRET requires a dataset of at least  
100 pixels, corresponding to region of 1 μm × 1 μm assuming a pixel size of 100 nm, for accurate 
determination of FRET efficiency; therefore, pixel-by-pixel documentation of “E” in an image is not 
possible. However, heterogeneity in spatial subsets due to biological variance can be explored when 
regions of interest are selected for analysis in the cell. With physiological settings, known to have low 
photon numbers due to weak expression of proteins and with abundant outer pixels of both biological 
and instrumental origins, we noted that MLE of FRET efficiency exceeds the performance of both 
pixel-by-pixel and total intensity based FRET approaches. The traditional method of calculating “E” 
suffers from distortion generated by detector noise, thus uncertainties prevail while calculating “E” for 
weakly expressed proteins. In fact, the FRET histogram would be wide and asymmetrical with large 
variance making “E” meaningless. Readers interested in the theoretical and mathematical background 
on this method can review our recently published paper [63]. The method was developed for confocal 
microscope; however, we do not see any reason why it cannot be adapted to flow cytometry as long as 
photon counting detectors are used. 
Spectral Analysis for FRET 
The idea of spectral analysis for FRET was borrowed from remote sensing and satellite imaging 
techniques [89]. The approach is to record a set of images in a series of wavelength bands, also 
referred to as lambda (λ) stacks. It is assumed that each fluorophore has its own specific spectral 
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signature, which can be identified within the λ stack. With these signature reference spectra of the 
fluorophores and autofluorescence, the contribution of each fluorophore and autofluorescence in a 
mixed spectrum, as in a FRET sample, can be easily identified, even with a high degree of spectral and 
spatial overlap, using linear unmixing algorithms [90–95]. Taking advantage of this feature, several 
FRET approaches have been described; in fact, in many of the cases spectral imaging was just used as 
an addendum to the traditional FRET approaches to increase accuracy [90,92,93]. However, separating 
acceptor bleed-through from FRET signal is very difficult to obtain with linear unmixing because of 
their identical emission spectrum. This approach is primarily suitable for two-photon microscopy 
where judicious selection of excitation wavelength could be achieved easily thus circumventing 
acceptor cross-excitation [96]. Typically, the emission spectra of the donor and acceptor contain all the 
information regarding the concentration of fluorophores and the FRET efficiency [97]. Despite the 
possibility in increased sensitivity offered by spectral FRET measurement, the whole approach is 
complicated and requires special hardware for recording “λ” stacks. Additionally, the idea to distribute 
emission spectra in a series of spectral intervals to multiple detector channels also demands 
modification in instrumental settings (e.g., laser power, line averaging or pixel dwell time) for each of 
these channels potentially making each of the acquired images noisy [94]. Spectral FRET analysis is 
primarily used in microscopy; however, it is also feasible in spectrofluorometry [92,95] and spectral 
flow cytometry. 
6.1.4. Donor Photobleaching Method 
Monitoring the photobleaching kinetics of donor in the presence or absence of acceptor also offers a 
simple approach to determine FRET. Photobleaching occurs from the excited state of a fluorophore. 
The stability of donors increases due to decrease in the availability of the excited state donor molecules 
when nearby acceptors are present due to FRET. Consequently, energy transfer decreases the rate  
of photobleaching and increases the bleaching time constant of the donor [57,82,98]. In contrast to  
the acceptor photobleaching technique, this approach requires a photolabile donor and photostable 
acceptor allowing determination of FRET efficiency [58,68,99]. This method also offers the advantage 
of being insensitive to expression density of proteins under investigation (since the kinetics of 
bleaching are measured which is assumed not to be influenced by the expression levels unless the 
expression level alters FRET), however, other environmental factors, like oxygenation, fluorophore 
concentration, temperature, etc., can still influence donor photobleaching. The measurements are not 
self-controlled; therefore, mixing singly and doubly labeled cells and measuring them on the same 
slide sequentially or simultaneously for the bleaching kinetics would reduce errors due to the above 
factors. Since pixel-by-pixel bleaching time can differ due to molecular environment or other factors, it 
is considered to be more effective with wide-field microscopy instead of confocal laser scanning 
microscopy [68,100]. Donor photobleaching can be correlated to the FRET efficiency using the 
equation below: 
E = 1 − ୈܶ
ୈܶ୅
 (17)
In Equation (17), TD and TDA stands for the photobleaching time constant of donor in the absence 
and presence of acceptor, respectively. For calculating time constants, a sequence of images of donor 
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from the corresponding samples are taken with donor-specific optical filter sets while bleaching the 
donor until it reaches the level of background. Since images are recorded at different times, the image 
stacks store the time-dependent fluorescence of the donor, or bleaching curve, which is fitted by the 
following exponential function resulting in the desired photobleaching constants [49,68,69,82]. 
ܫ୲ = ܫ଴eି
௧
் + ܾ݃ (18)
where It is the time dependent donor fluorescence intensity, I0 is the donor intensity before bleaching,  
t is time, T is the bleaching time constant and bg is the background. In some cases, a single exponential 
function is not sufficient to achieve reasonable fits. In these cases a double exponential fit may be  
carried out [57]. 
6.2. Fluorescence Lifetime Based Approach 
Fluorescence lifetime (τ) characterizes the time spent by fluorescent species at the excited state 
before exiting to the ground state by radiative and non-radiative mechanisms. Therefore, it is inversely 
proportional to the sum of all the kinetic processes: rate constant of fluorescence emission (k୤), rate 
constant of FRET (k୊ୖ୉୘), if present, and rate constant of all other non-fluorescent mechanisms (k୬୤), 
responsible for relaxation of the excited fluorophore. 
τୈ =
1
k୤ + k୬୤ , τୈ୅ =
1
k୤ + k୊ୖ୉୘ + k୬୤ (19)
where τD and τDA are the fluorescence lifetime of the donor in the absence and presence of the acceptor 
(i.e., FRET), respectively. 
A convenient way to measure fluorescent lifetime is to determine fluorescence emission decay 
which follows first-order kinetics for a simple fluorophore [101]. Fluorescence lifetime is 
mathematically defined as the time taken by a population of excited molecules to decay by a factor of e 
(or to 37% of the initial population) [62,102]. Each fluorophore has its own characteristic fluorescence 
decay pattern like unique spectral fingerprints. FRET introduces a new de-excitation pathway and 
consequently accelerates the relaxation process. Therefore, with the increase in the rate of FRET, the 
donor lifetime decreases because of proximity to acceptors [82]. Understandably, fluorescence lifetime 
provides a direct measure to determine FRET. For an excited fluorophore, the rate of return to the 
ground state depends on their number in the excited state times a rate constant, therefore, “E” can be 
expressed from fluorescence lifetimes as below: 
d[D∗]
dt = −[k୤ + k୬୤][D
∗] = − 1τୈ [D
∗] (20)
d[D୊ୖ୉୘∗ ]
dt = −[k୤ + k୊ୖ୉୘ + k୬୤][D୊ୖ୉୘
∗ ] = − 1τୈ୅ [D୊ୖ୉୘
∗ ] (21)
E = k୊ୖ୉୘k୊ୖ୉୘ + k୤ + k୬୤ =
k୊ୖ୉୘ + k୤ + k୬୤ − (k୤ + k୬୤)
k୊ୖ୉୘ + k୤ + k୬୤ = 1 −
τDA
τD  (22)
Equations (20) and (21) correspond to the first-order decay kinetics of donor only and FRET 
samples. In the above equations, [D∗] and [D୊ୖ୉୘∗ ] represent concentration of donors at excited state 
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for donor and FRET samples, respectively, at time “t”. The rate constants (k୤,	k୬୤	 and k୊ୖ୉୘) are 
described in Equation (19). 
Fluorescence lifetime based FRET (FL-FRET) can be carried out in a microscope, a spectrofluorometer 
or a flow cytometer. An important feature of FL-FRET is its ability to predict the fraction of  
acceptor-bound donor based on the fluorescence decay curve [19,94]. Fluorescence lifetime is also 
independent of fluorophore concentrations, emission of acceptors and instrumental factors. Therefore, 
FL-FRET does not suffer from the major issues seen in intensity analysis based FRET methods like 
spectral spillover, differences in local concentrations of fluorophores, variation in excitation intensity 
and exposure duration [35,62,101]. This means that the whole FRET experiment is simplified, 
requiring less experimental controls and normalization procedures. Therefore, it is highly valuable 
under conditions where the above experimental parameters are hard to control or determine. 
Fluorescence lifetime is determined by energetically unstable state of a fluorophore; therefore, it is 
sensitive to perturbations related to temperature, polarity, refractive index of medium and various 
quenching effects [35,102]. The exploitation of FL-FRET in microscopy also makes it possible to map 
the spatial and temporal lifetime dynamics of the molecule with increased accuracy. However,  
FL-FRET requires long acquisition times in microscopy. Additionally, most biologically relevant 
fluorophores exhibit lifetimes of nanoseconds. Therefore, fluorescence lifetime measurements also 
demand sophisticated and expensive instrumentation [103]. 
6.3. Fluorescence Anisotropy Based Approach 
Fluorophores are randomly oriented in space and time even in the case of fluorescently labeled 
plasma membrane protein. Imagining that polarized light excites a stationary fluorophore, the 
consequent fluorescence emission is also polarized in the same plane. Exposure to a polarized light 
typically leads to excitation of only a fraction of the total population of fluorophores. This is because 
fluorophores are free to enjoy any random orientations and only those fluorophores are excited whose 
absorption transition dipole is aligned suitably or nearly parallel to the polarization plane of the 
excitation source, a process called photoselection. Furthermore, during the excited state, fluorophores 
can demonstrate reorientation before they lose energy through both radiative and non-radiative 
mechanisms including FRET. Consequently, the emitted light is depolarized in comparison with the 
polarized excitation source [11]. Fluorescence anisotropy (r) defines how much fluorescence emission 
is polarized after polarized excitation. If a fluorophore is illuminated with a vertically polarized light, 
then, both vertical (Iv) and horizontal (Ih) emissions should be collected. Processes leading to 
depolarization of emission are then characterized by these two intensities based on anisotropy 
calculated according to Equation (23). 
r = ܫ୴ − ܫ୦ܫ୴ + 2ܫ୦ (23)
Anisotropy is sensitive to the size and shape of the molecule, rigidity or fluidity of the molecular 
environment, rotational motion and molecular association events [13]. Larger fluorophores will have 
slower mobility whereas smaller sized fluorophores will tumble and rotate faster. Therefore, larger 
species will have high anisotropy while small species will have low anisotropy values. However, it is 
not only the rotation of fluorophores that can alter anisotropy. Typically, FRET also alters the 
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anisotropy of the fluorophore (Figure 3) [11,13]. HeteroFRET shortens the donor's lifetime; therefore, 
the donor has less time to rotate during the excited state lifetime before emitting a photon. 
Consequently, donor emission is hyperpolarized (relative to the case when no heteroFRET takes place) 
resulting in an increase of anisotropy. HomoFRET does not affect lifetime but rather leads to the 
transfer of energy between like molecules. Each homoFRET step depolarizes the excited population 
since the acceptors excited by homoFRET are not parallel to the donor. Since the donor and the 
acceptor are spectroscopically identical, i.e., their fluorescence is indiscriminable, the eventual 
emission is less polarized with a resultant decrease in anisotropy. Importantly, ensemble fluorescence 
intensity and lifetime of donor are reduced in heteroFRET but remain unchanged in homoFRET. The 
extent of depolarization of the fluorophore emission in homoFRET depends on the oligomerization 
state of the proteins. The larger the number of molecules in a cluster, the lower the anisotropy of the 
overall fluorescence emission is [13,14]. This feature makes homoFRET a useful tool in the 
quantitative analysis of large protein clusters [14,104]. However, polarization artifacts induced by 
sample and instrumental factors easily influence this method. Optical lenses with high numerical 
aperture (>1) are also found to cause significant depolarization of the emission light. The apparent 
anisotropy decreases with the increase in numerical aperture of the objective lens. Therefore, 
objectives with lower numerical aperture are more accurate for anisotropy measurements although 
with loss in resolution and sensitivity [105]. Anisotropy measurements require highly expressed 
proteins because the emission signals from the fluorophores are significantly reduced due to the 
polarizer and also as a result of splitting of the emission signals into vertical and horizontal 
components [62,106]. Additionally, anisotropy is not very sensitive to the FRET efficiency. It is only 
suitable for providing information on the presence or absence of FRET, but cannot be used to measure 
small changes in FRET [62,94]. Nonetheless, both microscopic and flow-cytometric applications of 
anisotropy can be found in the literature [13,104]. 
7. Applications of FRET in Membrane Biology 
The exponential growth in studies applying FRET is explicitly tied to the acceptance of the 
technique by the biologists. FRET has influenced and impacted different domains of science whether it 
is molecular biology, cell biology or genetics. It is impossible to document each of these developments 
here; therefore, we are going to focus on the studies related to membrane biology which has been the 
subject of our investigation for three decades now. Lectin receptors were the first molecules to be 
studied in situ in the plasma membrane of a cell using FRET in 1976 [107], a couple of years after the 
proposition of the Singer-Nicholson fluid mosaic model, in 1972 [108]. Coincidentally, the discovery 
of monoclonal hybridoma technology also occurred at the same time, in 1975 [109]; however, the first 
study did not involve antibodies as an affinity reagent. Alongside the general acceptance of the cluster 
of differentiation (CD) classification of monoclonal antibodies starting in 1982 [110], the use of 
antibodies as probes for FRET has become dominant. The incentive for us to carry out research on cell 
surface receptors was the conviction that the plasma membrane was the interface for the cell to 
communicate with its extracellular environment and thus was subjected to dynamic changes, yet its 
molecules were not randomly distributed, but constantly reorganized as function required. Initial 
studies were also greatly helped by the availability of monoclonal antibodies against surface receptors 
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of leukocytes. Subsequently, we were able to show that distribution of proteins on the cell surface was 
non-random and dynamically changing [111]. Some of these findings on membrane molecules of 
lymphocytes and cancer cells will be re-iterated below to show the utility of FRET in biological 
systems, and to highlight the related or potential biological functions. 
7.1. Organization of Antigen Presenting Molecules in the Plasma Membrane of B Cells 
Conventionally, it was believed that only peptides were antigenic. However, the perception has 
changed over the last two decades with a broad range of smaller molecules being found capable of 
activating T cells. With the antigens also came the diversity in antigen presenting molecules: Major 
histocompatibility complex I and II (MHC I and MHC II) present peptides, Cluster of Differentiation 1 
(CD1) a, b, c, and d present lipid-based antigens, MHC related protein 1 (MR1) presents vitamin 
metabolites and butyrophilin presents phosphorylated antigen to T cells [112]. In the early 1980s, only 
peptide antigen presentation was assumed to induce adaptive immune response. Therefore, our initial 
research was focused on MHC proteins in order to reveal whether they exhibited specific topological 
features in the plasma membrane of cells. Previous studies demonstrated that antibodies against MHC I 
would co-cap MHC II molecules on the surface of B lymphocytes. It was an indirect indication of the 
proximity of MHC I and MHC II molecules [10,113]. Therefore, we decided to apply the more direct 
approach of FRET to investigate the association between MHC I and MHC II in B lymphoid  
cells [114,115]. For this purpose, a panel of monoclonal antibodies, conjugated with either FITC 
(donor) or TRITC (acceptor), and specific for MHC molecules were used. Cells were labeled 
simultaneously with fluoresceinated and rhodaminated antibodies, then, measurements were performed 
in a flow cytometer and FRET efficiency was calculated on a cell-by-cell basis (please refer to  
the section of Three-Channel Emission Measurement). Mean values of FRET efficiency distribution 
histograms for measured cells were used to ascertain the proximity relationship of MHC molecules. 
Results suggested that MHC I and MHC II proteins were physically associated already before  
co-capping. In addition, our FCET studies also revealed that MHC I and MHC II proteins can  
form homoclusters in the plasma membrane of resting cells [114,115]. Interestingly, MHC II  
isotypes, HLA-DP, HLA-DQ and HLA-DR, favored inter-isotype association instead of intra-isotype 
association [114], although intra-isotype association can also be found in B cell lines [114,116]. In  
a similar FCET approach, but using Alexa 546- and Alexa 647-conjugated antibodies as donors and 
acceptors, respectively—which is a better FRET-pair than FITC and TRITC—we also documented 
recently that CD1d, a lipid antigen-presenting molecule, is a part of the membrane domains that 
contain MHC I and MHC II. MHC I heavy chain and CD1d heavy chain is very similar in structure. 
Generally, both of these proteins require β2-microglobulin (β2m) to be bound non-covalently to acquire 
a functional state. FRET studies and quantitative determination of MHC I, CD1d and β2m protein 
numbers indicated that unlike MHC I, most of the CD1d proteins were free from β2m in the plasma 
membrane of C1R-CD1d cells, a B lymphoid cell line stably expressing CD1d [116]. The functional 
manifestation of β2m free CD1d is obscure, however, β2m free CD1d heavy chain has been found to 
activate T cells in mice [117]. We also noted a decrease in MHC II and increase in MHC I and β2m 
expression on the surface as a result of CD1d expression in this cell line [116]. It should be 
emphasized that the molecular association of MHC and CD1d proteins in the plasma membrane can 
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influence their biological functions. In this regard, MHC I association with CD1d on the cell surface 
has been found to diminish the ability of CD1d expressing antigen presenting cells to activate CD1d 
specific T cells [118] and MHC II surface expression has been observed to enhance CD1d-mediated 
antigen presentation [119] in previous studies. Further using FCET approach, we have shown that 
tetraspanin proteins (CD53, CD81 and CD82) were in close proximity of MHC I and MHC II in B 
cells [115], and subsequently other studies documented the important roles of tetraspanin in antigen 
presentation [120]. Immunoprecipitation experiments have also revealed the association of CD9 and 
CD82 with CD1a and CD1d in immature dendritic cells [121] and B cells [122]. Therefore, interaction 
with tetraspanin molecules seems to be a general feature of antigen presenting molecules. However, 
the roles of these tetraspanin proteins might differ between the antigen presenting cells owing to their 
differential impact on surface expression of antigen presenting molecules. For instance, using siRNA 
mediated gene silencing approach Hoorn et al. [123], demonstrated that silencing of CD9, CD63 or 
CD81 increased MHC II surface expression whereas no effect was observed when CD82 was silenced. 
The mechanisms responsible for such effects are unclear, nonetheless, it was presumed that the binding 
of CD63 possibly would delay the release of MHC II from the multivesicular bodies within the  
cell [123]. Tetraspanin proteins seem to organize into tetraspanin enriched domains in the plasma 
membrane mediating and recruiting several surface molecules including antigen presenting molecules, 
leukocyte receptors, integrins and signaling proteins. These proteins thereby are found to influence 
cellular functions such as intracellular signaling, antigen presentation, and migratory events [120]. 
Using FCET, we found that MHC I, CD1d and MHC II had different propensities for GM1 
ganglioside-rich regions, also called lipid rafts. MHC II (or CD1d) showed high FRET efficiency with 
GM1 gangliosides, whereas, MHC I exhibited only a small FRET efficiency. This finding shows that 
MHC II and CD1d favor the proximity of GM1 gangliosides whereas MHC I is primarily located in 
non-GM1 regions [116]. Rafts and tetraspanin domains display several similar attributes; however, 
differences also seem to exist between them but remain ambiguous. In this regard, FRET studies 
aiming to define the dynamical organization of these domains relative to MHC I, MHC II and CD1 
species before and during antigen presentation can provide valuable information. 
7.2. Cytokine Receptors and MHC Proteins in T Cells 
Application of flow-cytometric FRET to T cell surface also revealed the aforementioned 
interactions between MHC I and MHC II proteins [124,125] suggesting association of the two groups 
of MHC as a general feature in the plasma membrane of cells. Interestingly, co-immunoprecipitation 
studies had previously revealed molecular complexes of CD1a with CD1b, CD1c or MHC I heavy 
chain in normal thymus cells [126,127]. Based on these findings, it can be postulated that all CD1 
isoforms, if expressed, can partially co-exist in similar regions of the plasma membrane inhabited by 
MHC proteins although it seems that cells may rearrange protein organization under pathological 
conditions [128]. T cells express diverse set of interleukin receptors responsible for their life and  
death [129]. Therefore, we extended our FCET studies to demonstrate the proximity of interleukin 
receptors, IL2R and IL15R, with each other and with MHC proteins in the plasma membrane of  
T cells [124,130]. IL2 and IL15 receptors comprise three distinct subunits: a unique and cytokine-specific 
α-chain and the β and γ chains that are shared by both IL2R and IL15R. Due to common β and  
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γ chains, IL2R and IL15R can induce similar biological functions; however, they can also initiate 
distinct signaling mechanisms. The hetero-trimeric complex of α, β and γ subunits is the high-affinity 
state for these receptors to bind to their respective ligands IL2 and IL15 [129]. The much debated topic 
was the assembly of α, β and γ subunits for IL2R and IL15R in T cells. In the case of IL2R, it was 
assumed that α and β subunits existed separately in the absence of ligand (IL2) and pairing occurred 
only after the binding of α subunit with IL2. To determine the mechanisms of the assembly of  
hetero-trimeric complex of IL2R and IL15R, we applied FCET to map the proximity of α, β and γ 
subunits to each other on Kit 225 K6 human T-lymphoma cells using FITC- and Cy3-conjugated 
monoclonal antibodies. Experiments on these cytokine receptors revealed positive FRET efficiency 
between all the three subunits of IL2 and IL15 receptors even in the absence of ligand. These results 
suggested that at least a fraction of these receptors could exist in a hetero-trimeric high-affinity state in 
resting human T-lymphoma cells. The addition of cytokines (IL2 and IL15) led to a change in FRET 
efficiency reflecting the change in the association of receptor subunits. In general, cytokines (IL2  
and IL15) led to a tightening of the hetero-trimeric complex formed by the respective receptors.  
Homo-association and hetero-association was also seen for IL2Rα and IL15Rα both in the absence and 
presence of IL2 or IL15. Therefore, we proposed a hetero-tetrameric model of IL2/IL15 receptor 
complex comprising IL2Rα, IL15Rα, and the common β and γ chains. The surrounding environment 
thus dictates the molecular assembly for high-affinity receptor complex formation for IL2R or IL15R 
where specific cytokines favor respective high-affinity receptor trimeric complex while the unused  
α-chain (either IL2Rα or IL15Rα) is nudged from the site of cytokine–receptor interaction [130,131]. 
Considering the role of interleukin receptors in T cell homeostasis, the molecular organization of IL2R 
and IL15R in the plasma membrane might be of therapeutic relevance. IL2 and IL5 receptors were 
found to be upregulated in Crohn’s disease. The increased self-association of IL2Rα receptors  
but their decreased association with γ chains was revealed by FCET [132]. This indirectly suggests  
that both IL2Rα and IL15Rα receptor-based trans-presentation—a mechanism in which a surface 
interleukin receptor (α chain) can present the bound cytokine to nearby cells during cell–cell 
interaction [129]—could be the dominating cellular function in Crohn’s disease. Evidence of an 
excessive trans-presentation by IL15Rα during Wegener’s disease, an inflammatory disease similar to 
Crohn’s disease, supports the above notion [133]. Likewise, association of IL5Rα (or IL2Rα) with 
MHC I was consistently observed with FCET studies and this molecular association increased during 
Crohn’s disease. This is additional evidence regarding the potential secondary cellular function of 
MHC I beside antigen presentation. However, further studies will be required to prove such functions 
of MHC I. 
7.3. Dynamic Reorganization of Membrane Proteins in T Cells during Immune Synapse Formation 
Antigen recognition by T cells is fundamental in initiating adaptive immune response. For this 
process, it is necessary that antigen presenting cells (APCs) and T cells come closer to each other and 
form a functional immunological synapse. The hallmark of synapse formation is the interaction of  
T cell receptors (TCRs) with the cognate peptide-MHC complex and the simultaneous reorganization 
of co-stimulatory molecules, adhesion proteins and membranes in both cells [134]. The spatial and 
temporal details of molecular events occurring at the central region of the synapse have been a subject 
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of significant interest for several years now. FRET has been instrumental in defining these changes  
for transmembrane molecules and membrane-associated molecules in T cells before and during  
antigen recognition phase. The earliest demonstration of CD4 and CD3 reorganization in the plasma 
membrane of CD4 helper T cells was achieved by FCET. The study was not yet based on formation of 
an immunological synapse between APC and T cells; it was an antibody cross-linking study involving 
CD3, CD4 and CD45 proteins. Combinations of FITC and TRITC conjugated monoclonal antibodies 
against CD3, CD4 and CD45 were used as FRET-pairs. Increase in FRET efficiency between 
CD3/TCR and CD4, but no FRET between CD3/TCR and CD45 was observed when CD4 T cells were 
activated with anti-CD3 antibodies. This suggests that the immediate response of T cells on antigen 
recognition possibly would be the redistribution of proteins, with CD3/TCR coming closer to CD4 
while CD3/TCR being persistently distant from CD45 [135]. Later, the same group documented  
that the movement of CD4 towards CD3/TCR was dependent on the interaction of p56lck with the 
cytoplasmic domain of CD4, especially at positions 420 and 422 [136]. A few years later,  
Bacso et al. [137] demonstrated a possibility of measuring intercellular FRET between APCs and T 
cells undergoing immune synapse formation making a clever use of donor photobleaching FRET. 
Exploiting FITC and TRITC combination as a FRET-pair, they showed that in the cytotoxic T cell 
synapse, FRET occurred between CD8 (T cell) and MHC I (B cell) but not between adhesion 
molecules LFA1 (T cell) and ICAM1 (B cell). However, they observed a spatial heterogeneity in 
energy transfer between CD8 and MHC I (0%–30%) at contact regions between conjugates suggesting 
multiple points with varying degree of interactions. Since they did not observe any FRET between 
ICAM1 and LFA1, it was presumed that the labels on these adhesion molecules were located farther 
away than FRET distance (beyond 10 nm) [137]. 
Today, the synaptic region is defined as a central circle dominated by CD8 or CD4, CD3/TCR, 
CD28 and LAT proteins (known as central supramolecular activation complex, cSMAC), surrounded 
by an LFA1 and CD2 rich peripheral supramolecular activation complex (pSMAC), which is further 
surrounded by the distal SMAC region (dSMAC), containing mostly CD45, CD43 and CD44 
molecules [134]. With microscopic FRET based on GFP variants fused to CD3ζ and CD4, Zal et al. [52], 
documented that agonist and antagonist molecules differentially influenced association of TCR/CD3ζ 
with CD4 in the synaptic region. An increase in FRET efficiency between CD3ζ-CFP and CD4-YFP 
was observed as a result of MHC II presenting an agonist peptide, whereas, the same was not observed 
for antagonist peptide despite recruitment of both CD4 and TCR/CD3ζ to the membrane contact 
regions of APC and T cell. Instead, the antagonist had a negative impact on the close-range interaction 
between CD3ζ and CD4 formed because of agonist treatment [52]. They later on showed that the 
recruitment of co-receptor, CD8β-YFP, to the synapse is the result of non-cognate interaction between 
CD8 and MHC I, as it relied on MHC density, and was independent of antigen unlike TCR movement 
to the synapse. They observed that non-stimulatory antigen presented simultaneously with an  
antigenic peptide stimulated association of CD8β-YFP with TCR/CD3-CFP, especially between  
their cytoplasmic domains during recognition of cognate peptide-MHC proteins [138]. We also found 
a molecular level interaction between TCR and CD8α using microscopic acceptor photobleaching 
FRET. In this method, an observation of increased donor fluorescence after photobleaching the 
acceptors is an indication of molecular proximity. We found that synapses between the cells were not 
formed in the absence of CD8, corroborating the significance of CD8 in the stabilization of TCR-MHC 
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I interactions. Further, the interaction between TCR and CD3, and CD8 and CD3 was clearly observed 
but no FRET resulted between TCR and CD45, TCR and CD28, and, CD3 and CD45 within the 
synaptic region, the observation that is in line with the aforementioned study [139]. 
We also studied the topological features of CD45 isoforms, a protein tyrosine phosphatase, in the 
plasma membrane of T cells. Eight different isoforms of CD45 are found in T cells, but only five of 
them are significantly expressed in T cells. With FCET, we were able to characterize the organization 
of three of these isoforms, CD45R0, CD45RBC, and CD45RABC, in the plasma membrane of T cells. 
Homoassociation FRET measurement of cells labeled with 50:50 mixtures of Cy3 and Cy5 conjugated 
Fab’s antibody fragments against CD45 isoforms revealed significant FRET efficiency only for the 
CD45R0 isoform. Therefore, CD45R0 but not CD45RBC or CD45RABC was found to exist as 
homodimers on the cell surface. Comparatively, CD45R0 also preferentially formed heterodimers  
with CD4 and CD8 proteins. Interestingly, this observation paralleled the results that CD4-associated 
p56lck tyrosine kinase activity and cellular protein were elevated with a concomitant increase in TCR 
signaling events in CD45R0 sublines in comparison with CD45RBC expressing sublines. Therefore,  
a postulation was made on this basis regarding the homodimerization of CD45R0 on the cell surface 
and the consequentially increased pool of active CD4-associated p56lck tyrosine kinase [140]. 
7.4. Elucidating the Membrane Features of ErbB/HER Kinases 
Members of epidermal growth factor (EGF) receptor family, i.e., ErbB proteins, belong to 
transmembrane receptor tyrosine kinases (RTKs) which are implicated in diverse cellular functions, 
including proliferation, differentiation and migration. The ErbB family consists of four proteins: 
ErbB1 (HER1 or EGFR, epidermal growth factor receptor), ErbB2 (HER2), ErbB3 (HER3), and 
ErbB4 (HER4). The aberrant functioning of ErbB kinases is known to cause cancers of the breast, 
lung, brain, cervix, ovary, colon etc. [82,141]. In general, these proteins exist in various combinations 
in the plasma membrane. Reorganization and formation of kinase active homo- and hetero-oligomers 
are known to occur between family members upon ligand binding. Several polypeptide growth factors 
which are overproduced in tumors can bind to these ErbB proteins, except for ErbB2, leading to 
induction of intracellular signaling via phosphorylation of cytoplasmic tyrosine residues. Surprisingly 
heteroassociation of ErbB3, which is kinase deficient, with ErbB2, which has no physiological ligands, 
has been found to constitute the most potent mitogenic pairing among all ErbB combinations [9,141]. 
Due to the high expression of these proteins, availability of many model cancer cell lines, and the great 
therapeutic importance of ErbB proteins, these proteins have been among the most widely studied 
RTKs. In fact, these proteins present yet another convincing example to show that cellular fate is 
reflected by the distribution patterns of the molecular species in the membrane. Studies on ErbB 
proteins using various FRET approaches revealed that all ErbB kinases have formed homo- and 
hetero-assemblies in the plasma membrane [9,13,82,142]. We wanted to understand the degree of 
clustering of ErbB1 and ErbB2 receptors in cancer cell lines; therefore, we performed anisotropy-based 
homoFRET measurements in a flow cytometer. We formulated a theoretical model based on the 
dependence of fluorescence anisotropy on the fraction of monomers and the number of proteins in  
a single cluster. The theoretical curves from the model exhibited different anisotropy curves (and 
values) for different degrees of molecular clustering. Fitting this model to the anisotropy data obtained 
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from cells using anti-ErbB1 or anti-ErbB2 antibodies, we found that the majority of ErbB1 was 
monomeric in nature, whereas ErbB2 distributed as large homoclusters (~100 proteins) in the plasma 
membrane in the quiescent state. Stimulation with EGF—a ligand for ErbB1, or pertuzumab—an 
antibody that blocks ErbB2 dimerization, or heregulin—an ErbB3 or ErbB4 specific ligand caused  
the redistribution of ErbB1 and ErbB2. EGF and heregulin treatment decreased the homoclusters of 
ErbB2 whereas ErbB1 clusters showed increase in homoclustering upon EGF treatment [104]. We also 
noticed a negative correlation between ErbB2 homoassociation and ErbB2 tyrosine phosphorylation [104] 
or local ErbB3 concentration [143]. Therefore, we were interested in learning how the above 
treatments would affect the heteroassociation between ErbB1 and ErbB2. To gain insights into this 
feature, we applied a variant of the acceptor photobleaching method that we termed FRET-sensitized 
acceptor photobleaching (FSAB) technique to quantitate the ratio of ErbB1 and ErbB2 in their 
heteroclusters. In FSAB, acceptors within FRET distance of donors are excited at a higher rate than 
free acceptors owed to the additional excitation by FRET if excitation is carried out in the donor 
absorption range. Consequently, donor-bound acceptors are photobleached preferentially at a higher 
rate, and as a result, FRET efficiency drops to zero when all the acceptor molecules in FRET distance 
are bleached. The remaining acceptor signal is from those acceptors that were not in FRET distance 
from donors. Therefore, FRET-sensitized acceptor bleaching kinetics can be used for estimating the 
fraction of acceptors in the vicinity of donors. FSAB revealed that only about 10% of ErbB2 is in 
heteroclusters with ErbB1 in quiescent cells, and with EGF treatment, the amount of ErbB2 associated 
with ErbB1 is doubled [64]. This observation links the decrease in homoclustering of ErbB2 and 
underlies the increased formation of heteroassociation between ErbB1 with ErbB2 as a result of EGF 
treatment [104]. Overall, many of our FRET studies suggest that the large homoclusters of ErbB2  
act as a reservoir, which is used by ErbB1 and ErbB3 to form active heteroclusters upon ligand 
stimulation. We have also found that ErbB1 and ErbB2 associate with cell adhesion molecules, 
especially with integrin˗β1. Two-sided FRET [144] measurements that can reveal pairwise interactions 
among three chosen molecules indicated a degree of complementarity between ErbB homoassociation 
and its association with integrins, and delineated a correlation between this complementarity and 
resistance to humanized antibody therapy. Furthermore, FRET analysis of frozen sections from clinical 
glioblastoma samples has revealed a correlation between such heteroassociation and tumor grade and 
prognosis, pointing to the possible application of FRET in predictive diagnostics [145]. 
8. Conclusions 
FRET is definitely attractive because of its ability to report molecular behavior at a resolution far 
below the optical diffraction limit. Ironically, the requirement of FRET to have spectral overlap 
between the FRET-pair is also the source of artifacts. In general, higher spectral overlap yielding  
a better FRET signal necessitates more extensive corrections for non-FRET signals [68]. Therefore, 
separating FRET from non-FRET signal is a major challenge. Correcting for non-FRET signals can 
especially be a problem with fluorescent proteins which generally show broad excitation and emission 
spectra [37]. FL-FRET is insensitive to fluorophore concentration and spectral overlap, and thus, can 
be a reasonable alternative. In particular, knowing the photophysics of fluorophores or FPs and the 
caveats of the used FRET methodology helps to properly interpret the results of FRET experiments 
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and to come-up with the correct workarounds. Many FRET studies use ectopic expression of proteins. 
In such cases, it is advised to match the expression level of the proteins with the physiological 
expression levels and to evaluate the effect of fusion tags on protein localization and function to  
avoid any random molecular interactions. Examining the dependence of “E” on acceptor density or  
donor-acceptor ratio can also help in deciding whether the observed molecules associate randomly or 
non-randomly [15]. However, one has to keep in mind that not observing FRET does not necessarily 
indicate the absence of molecular association in all cases. Absence of FRET could be a result of steric 
hindrance for neighboring molecules or protein domains or the competition between the used  
FRET-pair antibodies or incomplete labeling [11,15]. The extreme sensitivity of FRET in the  
sub-10 nm distances is considered the advantage of FRET, however, it is also its drawback owing to 
the sharp dependence of energy transfer above or below R0 making long distance measurements,  
>10 nm, difficult [60]. To remedy this situation, various strategies have been demonstrated recently for 
carrying out FRET above 10 nm including the use of multiple acceptors [146] or nanomaterials as 
acceptors [147]. Dependence of FRET on “ĸ2” and uncertainty in “ĸ2” further complicates the 
calculation of FRET. Fluorophores attached via linker to the probe are free to rotate randomly 
(dynamic regime) and thus can reduce uncertainty of “ĸ2”, but not completely [15,60]. Especially for 
FPs, “ĸ2” of 2/3 may not hold true because FPs have longer rotational correlation-time, and therefore, 
are virtually static (static regime) in comparison with organic fluorophores during an excited state.  
It was shown that assuming a dynamic regime for FP rotation would overestimate the separation between 
FP FRET-pair significantly (by 10% near 0.5 and by 30% near 0.75 energy transfer efficiencies) when 
compared with the static regime for FP [148]. Hence, FRET is good at relative but not absolute 
distance measurements [60]. Additionally, the initial formalism of FRET (Equation (1)) was developed 
for a fixed system with one-donor and one-acceptor; therefore, it cannot predict “E” accurately  
in a biological case where several donors and acceptors interact simultaneously. In fact, it has been 
shown that FRET efficiency would increase when multiple acceptors are available for each donor by 
increasing the probability of each donor to transfer energy to any of the nearby acceptors [149,150]. 
One should also be careful while drawing conclusions from FRET efficiency because it is not always 
translatable to distance, particularly in the case of heterogeneous multi-protein systems. In general, 
most studies use FRET methods that provide FRET efficiency values as a result of ensemble 
measurement either of molecular events occurring in each pixel as in microscopy or per cell in flow 
cytometry. However, single-molecule FRET (smFRET) that requires monitoring of individual 
molecules for FRET changes can also be performed. A key advantage of smFRET is the possibility to 
avoid ensemble averaging in samples enabling detection of static heterogeneity, i.e., differences in 
molecules having various degrees of interactions, or dynamic heterogeneity, i.e., time-dependent 
changes in molecular associations [151]. Nonetheless, smFRET is not always required and the 
qualitative ensemble FRET experiments can still serve a wide range of life science studies. Assuming 
that all the factors except distance can be controlled via experimental conditions, then qualitative 
information can easily be obtained from the measured apparent FRET efficiency. With the growing list 
of extensively characterized fluorophores and development of easy to use analytical tools for FRET, 
we believe that any user with sufficient knowledge in the operation of microscopes or flow cytometer 
should be able to facilely measure FRET. Overall, FRET can be rewarding if known and applied 
Int. J. Mol. Sci. 2015, 16 6747 
 
 
correctly; however, it can also be a fretting experience if the underlying pitfalls and principles of  
FRET methods are not well understood leading to all sorts of confusion. 
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